Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CF-FLOW: Sildenafil in Cystic Fibrosis
NCT02057458Phase 2Completed
- Sponsor
- Augusta University
- Start
- Apr 2014
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ASP-001 in cystic fibrosis (CF), sponsored by Augusta University. Started Apr 2014; status: completed.
02
Drugs
ASP-001
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT02057458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02057458.